The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by age | Scientific Reports
Schematic presentation of ApoA-I peptide interaction with lipids. (A)... | Download Scientific Diagram
Western Blot of lipoprotein (ApoA1, ApoB100/48) and EV markers (Alix,... | Download Scientific Diagram
Apolipoprotein AI - Wikipedia
A) apoA-I genotyping was confirmed using genomic DNA extracted from... | Download Scientific Diagram
The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux - Journal of Biological Chemistry
IVD Antibody Development Services for ApoA, B, E Markers - Creative Biolabs
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-s
Determination of the number of apoA-I molecules in an A-I- POPC-97... | Download Scientific Diagram
ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease | Laboratory Investigation
The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease | PLOS ONE
IVD Antibody Development Services for ApoA, B, E Markers - Creative Biolabs
Biology | Free Full-Text | ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial | Scientific Reports
Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility.
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL - ScienceDirect
apoA-V Antibody (A-12) | SCBT - Santa Cruz Biotechnology
![Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation](https://cdn11.bigcommerce.com/s-e7c5fvpp1c/images/stencil/500x659/products/264034/260807/monoclonal__71134.1675353318.png?c=2 "Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation")
Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine -
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Abstract 15086: Associations Between Apolipoprotein A-I Proteoforms and Markers of Cardiometabolic Health | Circulation
IVD Antibody Development Services for Apolipoprotein A1 Marker - Creative Biolabs
